|SRX -- Australia Stock|| |
AUD 33.55 0.00 0.00%
Mr. Nigel Lange is Chief Commercial Officer of the Company effective 5 June, 2017. He joined Sirtex US in 2002, then set up Sirtex operations in Europe. Before joining Sirtex, Mr Lange held senior roles at Nordion Inc and has over 20 years of experience in the healthcare industry. Mr Lange is based in our regional office in Bonn, Germany, where he is responsible for the development and execution of the strategic direction of sales and marketing in Europe as well as the Middle East and Africa, a region which for Sirtex comprises a total of 20 countries with direct sales and distributor sales models.
CEO Since 2017
61 2 9964 8400 http://www.sirtex.com
The company has return on total asset (ROA)
of 17.25 %
which means that it generated profit of $17.25 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of 26.87 %
meaning that it generated $26.87 on every $100 dollars invested by stockholders.
Sirtex Medical Limited, a life-sciences company, develops and delivers oncology treatments using novel small particle technology in the Asia-Pacific, Europe, the Middle East, Africa, and North and South America. As of September 20, 2018, Sirtex Medical Limited operates as a subsidiary of CDH Genetech Limited. Sirtex Medical operates under Biotechnology classification in Australia and is traded on Australian Securities Exchange.Sirtex Medical Limited (SRX) is traded on Australian Securities Exchange in Australia and employs 292 people.
Sirtex Medical Leadership Team
|Darren Smith, CFO, Company Secretary|
|Richard Hill, Non-Executive Chairman of the Board|
|Neville Mitchell, Independent Non-Executive Director|
|Gilman Wong, CEO, Managing Director and Executive Director|
|Tom Duthy, Global Investor Relations Manager|
|Michael Mangano, President of Americas Region|
|Katherine Woodthorpe, Non-Executive Independent Director|
|Nigel Lange, CEO of Europe|
|John Eady, Non-Executive Deputy Chairman of the Board|
|Anthony Dixon, Executive Vice President of Sales and Marketing,EMEA|
|Robert Hardie, Global Head of Operations|
|Helen Kurincic, Independent Non-Executive Director|
|Kevin Richardson, CEO, Americas|
|Rueben Teo, CEO, Asia Pacific (APAC)|
|David Cade, Global Medical Director|
|Andrew McLean, CEO, Executive Director|
|Grant Boyce, Non-Executive Director|
Stock Performance Indicators
Most of Macroaxis users are at this time bullish on Sirtex Medical Limited. What is your outlook on investing in Sirtex Medical Limited? Are you bullish or bearish?
Currently Active Assets on Macroaxis
Also please take a look at World Market Map
. Please also try Financial Widgets
module to easily integrated macroaxis content with over 30 different plug-and-play financial widgets.